VSMD (Vasamed) Research & Development: $1.74 Mil (TTM As of Sep. 2006)


What is Vasamed Research & Development?

Vasamed VSMD Research & Development is $1.74 Mil as of Sep. 2006.

Research & Development is the aggregate amount of research and development expenses during the year. Vasamed's Research & Development for the three months ended in Sep. 2006 was $0.44 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2006 was $1.74 Mil.

Vasamed  (OTCPK:VSMD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Vasamed Research & Development Related Terms

Vasamed Research & Development Historical Data

* Premium members only.

The historical data trend for Vasamed's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasamed Research & Development Chart

Vasamed Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.53 1.88 1.18 3.73 2.06

Vasamed Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.43 0.41 0.46 0.44

Vasamed Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.74 Mil mean?
Vasamed (VSMD) has a Research & Development of $1.74 Mil as of Sep. 2006. Research and development expense is the total cost for research and development activities. View historical data on Vasamed and its competitors.
Is Vasamed's Research & Development too high?
Vasamed's current Research & Development is $1.74 Mil.
How does Vasamed's Research & Development compare to LENSF and WHSI?
Vasamed's Research & Development of $1.74 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Vasamed and its competitors. Vasamed's current Research & Development is $1.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasamed stock overvalued right now?
Vasamed (VSMD) has a current Research & Development of $1.74 Mil. The current Research & Development is $1.74 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Vasamed (VSMD), the current Research & Development is $1.74 Mil as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vasamed Business Description

Address 7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733
Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.